Decision support for managing heart disease risk
Part of Heart & circulation clinical trials.
This trial tests a decision-support tool to help manage cardiovascular risk in people with established heart or blood vessel disease. It aims to improve treatment plans and outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have documented heart or blood vessel disease, such as a past heart attack, stroke, bypass surgery, or blocked arteries seen on imaging.
- You are between 40 and 80 years old.
- You visit the cardiology or vascular medicine outpatient clinic.
- You understand Dutch well enough to fill out questionnaires.
- You are not in another study that affects your treatment, and your doctor expects you to live at least 2 more years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new tool to help patients and doctors decide together on the best procedure (like stents or bypass surgery) for blocked heart arteries. It aims to make the decision process clearer and more personalized.
This trial tests whether a live, electronic team of heart specialists (called a Heart Team) can make better treatment decisions for people with diabetes and severe blockages in all three main heart arteries. The goal is to see if this approach improves outcomes compared to usual care.
This study tests a way to help people with severe aortic stenosis make informed choices about treatment. It may help you talk with your heart team about options like valve replacement.
This trial tests a new decision support tool for people with ischemic heart disease (reduced blood flow to the heart). It aims to help doctors and patients make better treatment decisions. You may be able to join if you are hospitalized for various forms of heart disease and have significant blockages found during a heart catheterization.
This study tests a tool to help patients with high bleeding and clotting risks decide on the best dual antiplatelet therapy after complex stent placement for a heart attack. Doctors and patients will use the decision aid together to find the safest treatment plan.
This study tests whether extra shared decision-making support can help people choose the right blood thinner and reduce racial differences in anticoagulation treatment. It focuses on adults with atrial fibrillation who are starting an oral blood thinner for the first time.
Hear when a new Shared Decision Making trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.